Immunogenicity and Safety of Pentaxim™ in an Indian Population
NCT00259337
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
226
Enrollment
INDUSTRY
Sponsor class
Conditions
Diphtheria
Tetanus
Polio
Pertussis
Haemophilus Infections
Interventions
BIOLOGICAL:
Diphteria/Tetanus/Polio/Acellular Pertussis/Hib vaccine
Sponsor
Sanofi